Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

An exacerbation of acne often occurs in the first 2 to 4 weeks of therapy as the follicular epithelium ... for treating photodamage (actinic keratosis and lentigines). He concluded that adapalene ...

Keratosis pilaris is regarded as the most common follicular skin disease in children and occurs to a greater or lesser extent in 50–80 % of adolescents and 40 % of adults (1, 3–5). It must therefore ...

Article It can be difficult to distinguish between malignant melanoma, pigmented naevus and seborrheic keratosis. Curettage and punch biopsy are simple procedures that can be performed by a general ...

June 4, 2025 • In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in the Biden administration continues.